TomTeleRx said:

Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…

TomTeleRx said:

...compounded vs brand cost and coverage...

This debate comes up weekly and I think both sides have valid points:

Pro-brand: FDA-approved, manufacturing standards guaranteed, clinical trial data directly applicable

Pro-compounded: 10x cost savings, same active molecule, independent testing available, accessibility

My position: if you can afford brand or have insurance coverage, that's the gold standard. If not, properly tested compounded from a 503B pharmacy is a reasonable alternative. Neither side should shame the other.

A narrower follow-up, since the general answer is now clear:

What would you measure differently if you were starting again?

TrialTracker_MD said:

TomTeleRx said: ...compounded vs brand cost and coverage...

Telehealth prescriber review for cost and coverage: I've used 2 different telehealth platforms to get my GLP-1 prescription. Comparison:

I settled on the one that required labs — it shows they care about safety, not just prescribing volume.

Reporting back.

Follow-up — getting the denial reason in writing was the step that mattered. It named the criterion, and the criterion was a document I already had.

MASHdoc_SA said:

Telehealth prescriber review for cost and coverage: I've used 2 different telehealth platforms to get my GLP-1 prescription.

Financial impact of cost and coverage weight loss beyond medication cost:

• Groceries: SAVED $233/month (eating less)
• Restaurants: SAVED $163/month (fewer meals out)
• Alcohol: SAVED $113/month (stopped drinking)
• Life insurance: Premium REDUCED by $43/month (lower BMI)
• Copays: SAVED $63/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.